BCLS ACQUISITION CORP's ticker is BLSA and the CUSIP is G0904B105. A total of 48 filers reported holding BCLS ACQUISITION CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,138,000 | +4.1% | 213,377 | +2.8% | 0.10% | -29.9% |
Q2 2022 | $2,054,000 | +0.9% | 207,477 | +0.6% | 0.14% | -34.2% |
Q1 2022 | $2,036,000 | +0.7% | 206,257 | 0.0% | 0.22% | -38.1% |
Q4 2021 | $2,021,000 | +6.1% | 206,257 | +7.8% | 0.35% | +22.5% |
Q3 2021 | $1,905,000 | -5.4% | 191,272 | 0.0% | 0.29% | -3.7% |
Q2 2021 | $2,014,000 | -0.4% | 191,272 | 0.0% | 0.30% | -24.1% |
Q1 2021 | $2,022,000 | -1.7% | 191,272 | +3.6% | 0.40% | -31.7% |
Q4 2020 | $2,056,000 | – | 184,600 | – | 0.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 843,122 | $8,878,000 | 3.55% |
Finepoint Capital LP | 603,429 | $6,354,000 | 1.19% |
COMMODORE CAPITAL LP | 250,000 | $2,633,000 | 0.92% |
Asymmetry Capital Management, L.P. | 83,277 | $877,000 | 0.60% |
SPHERA FUNDS MANAGEMENT LTD. | 687,900 | $7,244,000 | 0.49% |
Samsara BioCapital, LLC | 300,000 | $3,159,000 | 0.39% |
Bain Capital Life Sciences Investors, LLC | 487,500 | $5,133,000 | 0.34% |
First Trust Capital Management L.P. | 191,272 | $2,014,000 | 0.30% |
Altium Capital Management LP | 100,000 | $1,053,000 | 0.24% |
RA Capital Management | 1,250,000 | $13,163,000 | 0.21% |